Demant A/S operates as a hearing healthcare company in Europe, North America, Asia, Pacific region, and internationally. It engages in the development, manufacture, and wholesale of hearing aids; owning and operating hearing care clinics; and offers hearing and balance assessment solutions used by audiologists, ENT doctors, and balance clinics. The company was formerly known as William Demant Holding A/S and changed its name to Demant A/S in March 2019. Demant A/S was founded in 1904 and is headquartered in Smørum, Denmark.
Valuation
P/E Ratio
17.45x
Forward P/E
13.27x
EPS
11.21
PEG Ratio
—
P/B Ratio
4.19x
Beta
0.74
Profitability
Revenue Growth
3.40%
Earnings Growth
-63.40%
Gross Margin
75.62%
Operating Margin
18.05%
Net Margin
6.73%
Return on Equity
24.20%
Return on Assets
6.93%
Financial Health
Debt / Equity
2.12x
Current Ratio
1.36x
Quick Ratio
0.81x
Free Cash Flow
3.3B
Dividends
Dividend Yield
—
Payout Ratio
0.00%
Ex-Dividend Date
2000-04-26
Source: Yahoo Finance
Price Target
Low
DKK 170.00
Average
DKK 232.44
High
DKK 310.00
Source: Yahoo Finance
No recent press releases found